An essential step in home monitoring of pulmonary diseases: reliability of measurements with portable spirometry
Öz
Purpose: Measurement of pulmonary function test (PFT) parameters is an essential component in diagnosing and monitoring pulmonary diseases. While traditional spirometers used in laboratories by trained technicians are the standard, they may face challenges including technical and accessibility issues. Portable spirometry might be a promising tool for remote monitoring. This study aims to evaluate the compatibility of data obtained by using a portable spirometer (MIR Spirobank®) versus traditional spirometry.
Materials and methods: Consecutive adult patients referred to the PFT laboratory from the outpatient clinic were included in this cross-sectional study. Each underwent PFT to obtain FVC, FEV1, FEV1/FVC, PEF, and FEF25-75 parameters. The intraclass correlation coefficient (ICC) was calculated, and Bland-Altman plots were created to evaluate the agreement of the measurements from the two devices.
Results: The mean age was 51.97±9.37 (33-72) years, and 56.7% of the 30 participants were male. Spirometry results indicated 56.7% normal, 33.3% obstructive, and 10% restrictive disorders using traditional methods, with compatible distributions observed for the portable spirometer (Kappa coefficient=0.656, p=0.0001). High agreement and correlation were found (p<0.0001), and the Bland-Altman plots showed good consistency between the devices.
Conclusion: Acceptable reliability may suggest the use of portable spirometry in telemedicine for assessing pulmonary diseases remotely and enhancing patient care.
Anahtar Kelimeler
Portable spirometer, Spirobank, pulmonary diseases, remote monitoring, telemedicine
Destekleyen Kurum
None
Etik Beyan
This study was carried out in accordance with the Helsinki Declaration and was approved by the Pamukkale University Non-Interventional Clinical Research Ethics Committee (approval number: 17; date: 01.10.2024).
Teşekkür
We would like to thank Teknikel Medikal for bestowing the MIR Spirobank® device outright.
Kaynakça
- Levine SM, Marciniuk DD. Global Impact of Respiratory Disease: What Can We Do, Together, to Make a Difference? Chest. 2022;161(5):1153-1154. doi:10.1016/j.chest.2022.01.014
- Bindler R, Haverkamp HC, O'Flanagan H, et al. Feasibility and acceptability of home monitoring with portable spirometry in young adults with asthma. J Asthma. 2023;60(7):1474-1479. doi:10.1080/02770903.2022.2160345
- Park HJ, Rhee CK, Yoo KH, Park YB. Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry. Tuberc Respir Dis (Seoul). 2021;84:274-281. doi:10.4046/trd.2021.0016
- Kupczyk M, Hofman A, Kołtowski Ł, et al. Home self-monitoring in patients with asthma using a mobile spirometry system. J Asthma. 2021;58(4):505-511. doi:10.1080/02770903.2019.1709864
- Zhou J, Li X, Wang X, Yu N, Wang W. Accuracy of portable spirometers in the diagnosis of chronic obstructive pulmonary disease A meta-analysis. NPJ Prim Care Respir Med. 2022;32(1):15. doi:10.1038/s41533-022-00275-x
- Lin CH, Cheng SL, Wang HC, et al. Novel App-Based Portable Spirometer for the Early Detection of COPD. Diagnostics (Basel). 2021;11(5):785. doi:10.3390/diagnostics11050785
- Saryal SB, Ulubay G, editors. Solunum Fonksiyon Testleri. Toraks Kitapları, Sayı 16. İstanbul: AVES Yayıncılık; 2012.
- Heffler E, Crimi C, Mancuso S, et al. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48-52. doi:10.1016/j.rmed.2018.07.015
- Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health. 2020;8(3):e000530. doi:10.1136/fmch-2020-000530
- Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27(6):957-962. doi:10.1093/jamia/ocaa067
